Synthetic peptide immunotherapeutic: Expanded Phase I trials to evaluate the levels of cytotoxic T cell (CTL) activity directed against HIV, and to monitor the

United Biomedical Inc., Hauppauge,

Read the full 43 word article

How to gain access

Continue reading with a
two-week free trial.